Summit Therapeutics Inc (NAS:SMMT)
$ 13.66 -1.31 (-8.75%) Market Cap: 10.90 Bil Enterprise Value: 10.23 Bil PE Ratio: 0 PB Ratio: 16.82 GF Score: 27/100

Q1 2025 Summit Therapeutics Inc Earnings Call Transcript

May 1, 2025 / 08:30 PM GMT
Release Date Price: $24.67 (+2.28%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

SMMT.OQ - Summit Therapeutics Inc
Q1 2025 Summit Therapeutics Inc Earnings Call
May 01, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
For standing by. Hello and welcome to the Summit Therapeutics Q1 2025 earns conference call. I would now like to turn the call over to our chief business and strategy officer, Dave Vanars. Please go ahead, sir.

--------------------------------------------------------------------------------
Unidentified_3 [3]
--------------------------------------------------------------------------------
Good afternoon and thank you for joining us. A press release was issued earlier this afternoon and is
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot